P300
Showing 51 - 75 of >10,000
Schizophrenia Trial in Lyon (Cognitive remediation, psychosocial rehabilitation)
Recruiting
- Schizophrenia
- Cognitive remediation
- psychosocial rehabilitation
-
Lyon, Rhône, Francecentre de réhabilitation - Hôpital le Vinatier
Aug 11, 2022
COPD Trial in Worldwide (Itepekimab (SAR440340), Placebo, Any Inhaled Corticosteroids as prescribed by treating physician as
Completed
- Chronic Obstructive Pulmonary Disease
- SAR440340
- +5 more
-
Los Angeles, California
- +82 more
Oct 28, 2022
Bone Metastasis, Cancer Pain Trial in Worldwide (Tanezumab)
Completed
- Bone Metastasis
- Cancer Pain
-
Rosario, Santa FE, Argentina
- +88 more
Dec 21, 2022
Obesity, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (Tirzepatide, Placebo)
Recruiting
- Obesity
- Heart Failure With Preserved Ejection Fraction
- Tirzepatide
- Placebo
-
Huntsville, Alabama
- +144 more
Jan 18, 2023
Type 2 Diabetes, Chronic Kidney Diseases Trial in Worldwide (Cotadutide 100 micrograms, Cotadutide 300 micrograms, Cotadutide
Completed
- Type 2 Diabetes Mellitus
- Chronic Kidney Diseases
- Cotadutide 100 micrograms
- +4 more
-
Box Hill, Australia
- +64 more
Mar 28, 2022
Ulcerative Colitis Trial in United States (PF-06826647 100 mg QD, PF-06826647 300 mg QD, PF-06826647 600 mg QD)
Withdrawn
- Ulcerative Colitis
- PF-06826647 100 mg QD
- +4 more
-
Canoga Park, California
- +23 more
Dec 15, 2020
Stress Trial in Atlanta (Chiropractic adjustment using an activator)
Recruiting
- Stress
- Chiropractic adjustment using an activator
-
Atlanta, GeorgiaLife University Center for Chiropractic Research
Feb 17, 2022
Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Completed
- Type 2 Diabetes Mellitus
- LY3209590
- Insulin Degludec
-
Sheffield, Alabama
- +63 more
Oct 6, 2022
Arthritis, Psoriatic Trial in Worldwide (Placebo matching BMS-945429, BMS-945429)
Completed
- Arthritis, Psoriatic
- Placebo matching BMS-945429
- BMS-945429
-
San Diego, California
- +48 more
Oct 7, 2021
Healthy Trial in Rochester (TopSpin360)
Recruiting
- Healthy
- TopSpin360
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 22, 2023
Type 1 Diabetes, Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Not yet recruiting
- Type 1 Diabetes
- Diabetes
- LY3209590
- Insulin Degludec
-
Concord, California
- +86 more
Aug 17, 2022
Allergic Rhinitis Due to Dermatophagoides Farinae, Allergic Rhinitis Due to Dermatophagoides Pteronyssinus, Allergic Rhinitis
Active, not recruiting
- Allergic Rhinitis Due to Dermatophagoides Farinae
- +2 more
- Sublingual allergy immunotherapy tablet
- Placebo
-
Bakersfield, California
- +116 more
Dec 8, 2022
Substance Use Disorders Trial in San Juan (QEEG-Guided sLoreta Neurofeedback Training)
Not yet recruiting
- Substance Use Disorders
- QEEG-Guided sLoreta Neurofeedback Training
-
San Juan, Puerto RicoAdministración de Servicios de Salud Mental y Contra la Adicción
Jun 15, 2023
Coronary and Carotid Atherosclerotic Disease and Links With
Completed
- Vascular Disease
-
Los Angeles, California
- +68 more
Feb 22, 2022
NSCLC Trial in Worldwide (Datopotamab deruxtecan, Durvalumab, Carboplatin)
Recruiting
- NSCLC
- Datopotamab deruxtecan
- +6 more
-
Phoenix, Arizona
- +227 more
Jan 17, 2023
Pulmonary Arterial Hypertension Trial in Worldwide (rodatristat ethyl 300 mg tablet BID, rodatristat ethyl 600 mg BID, Placebo)
Recruiting
- Pulmonary Arterial Hypertension
- rodatristat ethyl 300 mg tablet BID
- +2 more
-
Phoenix, Arizona
- +59 more
Jul 11, 2022
System for Acute and Prolonged Disorders of Consciousness
Enrolling by invitation
- Disorder of Consciousness
- Routine clinical rehabilitation
-
Beijing, ChinaXuan Wu hospitial, capical medical university
Oct 18, 2023
Healthy Trial in Rochester (Synaquell(TM), Placebo)
Not yet recruiting
- Healthy
- Synaquell(TM)
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 25, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
Triple Negative Breast Cancer, PD-L1 Negative Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Paclitaxel,
Recruiting
- Triple Negative Breast Cancer
- PD-L1 Negative
- Sacituzumab Govitecan-hziy
- +4 more
-
Anchorage, Alaska
- +231 more
Jan 17, 2023